Abstract
We compared the use of low-dose G-CSF (50 μ g/m2/day), following salvage chemotherapy, for mobilization of PBSC with the results obtained in a comparable historical control group who received a standard dose of G-CSF (5 μ g/kg/day, approximately 200 μ g/m2/day). Thirty adult patients with relapsed or refractory lymphoma were treated with ifosfamide, VP-16, intermediate-dose Ara-C, methylprednisolone (IAPVP-16) and G-CSF 5 μ g/kg/day (group A, n = 15) or 50 μ g/m2/day (group B, n = 15) from day 6 until the end of leukaphereses. The duration of neutropenia and thrombocytopenia were equal in both groups. A median of two (1–3) leukaphereses were performed in both groups to harvest >3.5 × 106/kg CD34+ cells. The numbers of circulating CD34+ cells on the first day of leukocyte recovery were similar in both groups in those patients mobilized after a first cycle of IAPVP-16. The numbers of circulating CD34+ cells were similar in patients mobilized after a first and after a second IAPVP-16 in group A. In the low-dose group (group B), however, the numbers of circulating CD34+ cells were significantly lower in those mobilized after a second than after a first course. Additionally, the product of the first leukapheresis contained significantly fewer CD34+ cells in those mobilized after a second course only in group B, with no differences in group A. Nevertheless, the final products harvested did not differ in the content of MNC, CFU-GM and CD34+ cells, suggesting that these differences are not clinically important. These results indicate that the use of low-dose G-CSF (50 μ g/m2/day) is as effective as 5 μ g/kg/day in accelerating neutrophil recovery and mobilizing CD34+ cells after a first cycle of IAPVP-16 salvage chemotherapy, resulting in a substantial decrease in costs, while more heavily pretreated patients may require higher doses of G-CSF for an equivalent mobilization.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martínez, C., Sureda, A., Martino, R. et al. Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 μ g/m2) after salvage chemotherapy for lymphoma. Bone Marrow Transplant 20, 855–858 (1997). https://doi.org/10.1038/sj.bmt.1700990
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700990
Keywords
This article is cited by
-
Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients
Bone Marrow Transplantation (2005)
-
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders
Bone Marrow Transplantation (2000)
-
A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer
Bone Marrow Transplantation (2000)